Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Joshua Rhett and John O'Bryan.
Joshua Rhett
Connection Strength
1.106
John O'Bryan
  1. Biology, pathology, and therapeutic targeting of RAS. Adv Cancer Res. 2020; 148:69-146.
    View in: PubMed
    Score: 0.729
  2. Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants. Cell Rep. 2022 02 08; 38(6):110322.
    View in: PubMed
    Score: 0.203
  3. Therapeutic targeting of RAS: New hope for drugging the "undruggable". Biochim Biophys Acta Mol Cell Res. 2020 02; 1867(2):118570.
    View in: PubMed
    Score: 0.174
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.